Respinomycin A2

Respinomycin A2 is an anthracycline antibiotic that causes the differentiation of leukemic K-562 cells[1].

Product Specifications

CAS Number

[151233-04-4]

UNSPSC

12352005

Target

Antibiotic; Bacterial

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Infection

Smiles

[H][C@@]12OC3=C([C@@](O1)([C@H]([C@H]([C@@H]2O)N(C)C)OC4CC(N)(C(C(O4)C)OC5OC(C(C(C5OC)(C)O)O)C)C)C)C=CC6=C3C(C7=C(C8=C(C[C@@](O)(C(C8)OC)C)C=C7C6=O)O)=O

Molecular Formula

C43H58N2O15

Molecular Weight

842.93

References & Citations

[1]M Ubukata, et al. Respinomycins A1, A2, B, C and D, a novel group of anthracycline antibiotics. II. Physico-chemical properties and structure elucidation. J Antibiot (Tokyo) . 1993 Jun;46 (6) :942-51.